The long tail of a demon drug: The ‘bath salts’ risk environment

Using the case of synthetic cathinones (commonly referred to as ‘bath salts’ in the US context), this paper analyses structural factors surrounding novel psychoactive substances (NPS) as contributing to the unique risk environment surrounding their use. Drawing on interviews with 39 people who use b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The International journal of drug policy 2018-01, Vol.51, p.111-116
Hauptverfasser: Elliott, Luther, Benoit, Ellen, Campos, Stephanie, Dunlap, Eloise
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 116
container_issue
container_start_page 111
container_title The International journal of drug policy
container_volume 51
creator Elliott, Luther
Benoit, Ellen
Campos, Stephanie
Dunlap, Eloise
description Using the case of synthetic cathinones (commonly referred to as ‘bath salts’ in the US context), this paper analyses structural factors surrounding novel psychoactive substances (NPS) as contributing to the unique risk environment surrounding their use. Drawing on interviews with 39 people who use bath salts from four U.S. cities and analysis of the infrastructural, social, economic, and policy contexts, we document the unique harms related to changing contexts for illicit drug regulation, manufacture, and consumption. Findings suggest that NPS and designer drug markets, which are highly reliant upon the internet, share characteristics of the entertainment industry which has come to rely more heavily upon profits derived from the ‘long tail’ of myriad lesser-known products and the diminished centrality of ‘superstars’ and ‘hits’. Findings point toward increased theoretical and policy attention to changing drug market structures, more rigorous evaluations of drug ‘analogues’ legislation and greater involvement with NPS education and testing by harm reduction agencies.
doi_str_mv 10.1016/j.drugpo.2017.10.007
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5762257</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0955395917303274</els_id><sourcerecordid>2019056499</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-ac087609a342c2a22f8cfc466d1e56e6f0f838be53b5fa8af4c3449ebc8cd8173</originalsourceid><addsrcrecordid>eNp9kMtqGzEUhkVoSJzLG5Qi6HpcSSONpC4KJW3SQCAbZy00miNb7njkSmNDdnmM9vXyJJnBzqWbrA6cc_4LH0IfKZlSQqsvy2mTNvN1nDJC5bCaEiIP0IQqWRZcCvUBTYgWoii10MfoJOclIYRTTo_QMdOMKyXZBP2YLQC3sZvj3oYWR48tbmAVOzy6f8Xj-fHhb237Bc627fPjwz-cQv6NoduGFLsVdP0ZOvS2zXC-n6fo7vLn7OJXcXN7dX3x_aZwgvK-sI4oWRFtS84cs4x55bzjVdVQEBVUnnhVqhpEWQtvlfXclZxrqJ1yjaKyPEXfdr7rTb2Cxg3RybZmncLKpnsTbTD_X7qwMPO4NUJWjInR4PPeIMU_G8i9WcZN6obOZqCoiai41sMX3325FHNO4F8SKDEje7M0O_ajSo7bgf0g-_S23YvoGfZrfRgYbQMkk12AzkETErjeNDG8n_AE-AGZuw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2019056499</pqid></control><display><type>article</type><title>The long tail of a demon drug: The ‘bath salts’ risk environment</title><source>MEDLINE</source><source>PAIS Index</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Access via ScienceDirect (Elsevier)</source><creator>Elliott, Luther ; Benoit, Ellen ; Campos, Stephanie ; Dunlap, Eloise</creator><creatorcontrib>Elliott, Luther ; Benoit, Ellen ; Campos, Stephanie ; Dunlap, Eloise</creatorcontrib><description>Using the case of synthetic cathinones (commonly referred to as ‘bath salts’ in the US context), this paper analyses structural factors surrounding novel psychoactive substances (NPS) as contributing to the unique risk environment surrounding their use. Drawing on interviews with 39 people who use bath salts from four U.S. cities and analysis of the infrastructural, social, economic, and policy contexts, we document the unique harms related to changing contexts for illicit drug regulation, manufacture, and consumption. Findings suggest that NPS and designer drug markets, which are highly reliant upon the internet, share characteristics of the entertainment industry which has come to rely more heavily upon profits derived from the ‘long tail’ of myriad lesser-known products and the diminished centrality of ‘superstars’ and ‘hits’. Findings point toward increased theoretical and policy attention to changing drug market structures, more rigorous evaluations of drug ‘analogues’ legislation and greater involvement with NPS education and testing by harm reduction agencies.</description><identifier>ISSN: 0955-3959</identifier><identifier>EISSN: 1873-4758</identifier><identifier>DOI: 10.1016/j.drugpo.2017.10.007</identifier><identifier>PMID: 29248872</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Alkaloids - pharmacology ; Cities ; Consumption ; Drug and Narcotic Control - economics ; Drug and Narcotic Control - methods ; Drug and Narcotic Control - organization &amp; administration ; Drug markets ; Drug policy ; Drugs ; Entertainment industry ; Harm Reduction ; Health Risk Behaviors ; Humans ; Internet ; Legislation ; Legislation, Drug - organization &amp; administration ; Markets ; Novel psychoactive substances ; Profits ; Psychotropic drugs ; Psychotropic Drugs - pharmacology ; Regulation ; Risk assessment ; Risk environment ; Stimulants ; Street Drugs - pharmacology ; Substance-Related Disorders - prevention &amp; control ; Synthetic cathinones ; United States</subject><ispartof>The International journal of drug policy, 2018-01, Vol.51, p.111-116</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Jan 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-ac087609a342c2a22f8cfc466d1e56e6f0f838be53b5fa8af4c3449ebc8cd8173</citedby><cites>FETCH-LOGICAL-c514t-ac087609a342c2a22f8cfc466d1e56e6f0f838be53b5fa8af4c3449ebc8cd8173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.drugpo.2017.10.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27866,27924,27925,30999,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29248872$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elliott, Luther</creatorcontrib><creatorcontrib>Benoit, Ellen</creatorcontrib><creatorcontrib>Campos, Stephanie</creatorcontrib><creatorcontrib>Dunlap, Eloise</creatorcontrib><title>The long tail of a demon drug: The ‘bath salts’ risk environment</title><title>The International journal of drug policy</title><addtitle>Int J Drug Policy</addtitle><description>Using the case of synthetic cathinones (commonly referred to as ‘bath salts’ in the US context), this paper analyses structural factors surrounding novel psychoactive substances (NPS) as contributing to the unique risk environment surrounding their use. Drawing on interviews with 39 people who use bath salts from four U.S. cities and analysis of the infrastructural, social, economic, and policy contexts, we document the unique harms related to changing contexts for illicit drug regulation, manufacture, and consumption. Findings suggest that NPS and designer drug markets, which are highly reliant upon the internet, share characteristics of the entertainment industry which has come to rely more heavily upon profits derived from the ‘long tail’ of myriad lesser-known products and the diminished centrality of ‘superstars’ and ‘hits’. Findings point toward increased theoretical and policy attention to changing drug market structures, more rigorous evaluations of drug ‘analogues’ legislation and greater involvement with NPS education and testing by harm reduction agencies.</description><subject>Alkaloids - pharmacology</subject><subject>Cities</subject><subject>Consumption</subject><subject>Drug and Narcotic Control - economics</subject><subject>Drug and Narcotic Control - methods</subject><subject>Drug and Narcotic Control - organization &amp; administration</subject><subject>Drug markets</subject><subject>Drug policy</subject><subject>Drugs</subject><subject>Entertainment industry</subject><subject>Harm Reduction</subject><subject>Health Risk Behaviors</subject><subject>Humans</subject><subject>Internet</subject><subject>Legislation</subject><subject>Legislation, Drug - organization &amp; administration</subject><subject>Markets</subject><subject>Novel psychoactive substances</subject><subject>Profits</subject><subject>Psychotropic drugs</subject><subject>Psychotropic Drugs - pharmacology</subject><subject>Regulation</subject><subject>Risk assessment</subject><subject>Risk environment</subject><subject>Stimulants</subject><subject>Street Drugs - pharmacology</subject><subject>Substance-Related Disorders - prevention &amp; control</subject><subject>Synthetic cathinones</subject><subject>United States</subject><issn>0955-3959</issn><issn>1873-4758</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>7TQ</sourceid><recordid>eNp9kMtqGzEUhkVoSJzLG5Qi6HpcSSONpC4KJW3SQCAbZy00miNb7njkSmNDdnmM9vXyJJnBzqWbrA6cc_4LH0IfKZlSQqsvy2mTNvN1nDJC5bCaEiIP0IQqWRZcCvUBTYgWoii10MfoJOclIYRTTo_QMdOMKyXZBP2YLQC3sZvj3oYWR48tbmAVOzy6f8Xj-fHhb237Bc627fPjwz-cQv6NoduGFLsVdP0ZOvS2zXC-n6fo7vLn7OJXcXN7dX3x_aZwgvK-sI4oWRFtS84cs4x55bzjVdVQEBVUnnhVqhpEWQtvlfXclZxrqJ1yjaKyPEXfdr7rTb2Cxg3RybZmncLKpnsTbTD_X7qwMPO4NUJWjInR4PPeIMU_G8i9WcZN6obOZqCoiai41sMX3325FHNO4F8SKDEje7M0O_ajSo7bgf0g-_S23YvoGfZrfRgYbQMkk12AzkETErjeNDG8n_AE-AGZuw</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Elliott, Luther</creator><creator>Benoit, Ellen</creator><creator>Campos, Stephanie</creator><creator>Dunlap, Eloise</creator><general>Elsevier B.V</general><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7TQ</scope><scope>8BJ</scope><scope>DHY</scope><scope>DON</scope><scope>FQK</scope><scope>JBE</scope><scope>5PM</scope></search><sort><creationdate>20180101</creationdate><title>The long tail of a demon drug: The ‘bath salts’ risk environment</title><author>Elliott, Luther ; Benoit, Ellen ; Campos, Stephanie ; Dunlap, Eloise</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-ac087609a342c2a22f8cfc466d1e56e6f0f838be53b5fa8af4c3449ebc8cd8173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Alkaloids - pharmacology</topic><topic>Cities</topic><topic>Consumption</topic><topic>Drug and Narcotic Control - economics</topic><topic>Drug and Narcotic Control - methods</topic><topic>Drug and Narcotic Control - organization &amp; administration</topic><topic>Drug markets</topic><topic>Drug policy</topic><topic>Drugs</topic><topic>Entertainment industry</topic><topic>Harm Reduction</topic><topic>Health Risk Behaviors</topic><topic>Humans</topic><topic>Internet</topic><topic>Legislation</topic><topic>Legislation, Drug - organization &amp; administration</topic><topic>Markets</topic><topic>Novel psychoactive substances</topic><topic>Profits</topic><topic>Psychotropic drugs</topic><topic>Psychotropic Drugs - pharmacology</topic><topic>Regulation</topic><topic>Risk assessment</topic><topic>Risk environment</topic><topic>Stimulants</topic><topic>Street Drugs - pharmacology</topic><topic>Substance-Related Disorders - prevention &amp; control</topic><topic>Synthetic cathinones</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elliott, Luther</creatorcontrib><creatorcontrib>Benoit, Ellen</creatorcontrib><creatorcontrib>Campos, Stephanie</creatorcontrib><creatorcontrib>Dunlap, Eloise</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>PAIS Index</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The International journal of drug policy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elliott, Luther</au><au>Benoit, Ellen</au><au>Campos, Stephanie</au><au>Dunlap, Eloise</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The long tail of a demon drug: The ‘bath salts’ risk environment</atitle><jtitle>The International journal of drug policy</jtitle><addtitle>Int J Drug Policy</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>51</volume><spage>111</spage><epage>116</epage><pages>111-116</pages><issn>0955-3959</issn><eissn>1873-4758</eissn><abstract>Using the case of synthetic cathinones (commonly referred to as ‘bath salts’ in the US context), this paper analyses structural factors surrounding novel psychoactive substances (NPS) as contributing to the unique risk environment surrounding their use. Drawing on interviews with 39 people who use bath salts from four U.S. cities and analysis of the infrastructural, social, economic, and policy contexts, we document the unique harms related to changing contexts for illicit drug regulation, manufacture, and consumption. Findings suggest that NPS and designer drug markets, which are highly reliant upon the internet, share characteristics of the entertainment industry which has come to rely more heavily upon profits derived from the ‘long tail’ of myriad lesser-known products and the diminished centrality of ‘superstars’ and ‘hits’. Findings point toward increased theoretical and policy attention to changing drug market structures, more rigorous evaluations of drug ‘analogues’ legislation and greater involvement with NPS education and testing by harm reduction agencies.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>29248872</pmid><doi>10.1016/j.drugpo.2017.10.007</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0955-3959
ispartof The International journal of drug policy, 2018-01, Vol.51, p.111-116
issn 0955-3959
1873-4758
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5762257
source MEDLINE; PAIS Index; Applied Social Sciences Index & Abstracts (ASSIA); Access via ScienceDirect (Elsevier)
subjects Alkaloids - pharmacology
Cities
Consumption
Drug and Narcotic Control - economics
Drug and Narcotic Control - methods
Drug and Narcotic Control - organization & administration
Drug markets
Drug policy
Drugs
Entertainment industry
Harm Reduction
Health Risk Behaviors
Humans
Internet
Legislation
Legislation, Drug - organization & administration
Markets
Novel psychoactive substances
Profits
Psychotropic drugs
Psychotropic Drugs - pharmacology
Regulation
Risk assessment
Risk environment
Stimulants
Street Drugs - pharmacology
Substance-Related Disorders - prevention & control
Synthetic cathinones
United States
title The long tail of a demon drug: The ‘bath salts’ risk environment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T08%3A20%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20long%20tail%20of%20a%20demon%20drug:%20The%20%E2%80%98bath%20salts%E2%80%99%20risk%20environment&rft.jtitle=The%20International%20journal%20of%20drug%20policy&rft.au=Elliott,%20Luther&rft.date=2018-01-01&rft.volume=51&rft.spage=111&rft.epage=116&rft.pages=111-116&rft.issn=0955-3959&rft.eissn=1873-4758&rft_id=info:doi/10.1016/j.drugpo.2017.10.007&rft_dat=%3Cproquest_pubme%3E2019056499%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2019056499&rft_id=info:pmid/29248872&rft_els_id=S0955395917303274&rfr_iscdi=true